Endogenous peroxynitrite generation causes a subsequent suppression of coronary arterial contraction to serotonin

被引:7
作者
Davidson, CA [1 ]
Kaminski, PM [1 ]
Wolin, MS [1 ]
机构
[1] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 1997年 / 1卷 / 03期
关键词
nitric oxide; peroxynitrite; redox; superoxide anion;
D O I
10.1006/niox.1997.0128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High levels of exogenous peroxynitrite (ONOO-) have been reported to cause coronary vascular relaxation by a mechanism that appears to involve the subsequent generation of nitric oxide (NO). In this study, we examined if endogenous vasoactive levels of ONOO- are formed from endogenous superoxide anion (O-2(radical anion)) upon exposure of isolated endothelium-removed bovine coronary arteries (BCA) to biological levels of NO, During exposure of ECA to similar to 50 nM NO for 2 min, the level of endogenous O-2(radical anion) detected by lucigenin-dependent chemiluminescence (CL) was markedly decreased and an increase in luminol-dependent CL was observed, consistent with the detection of ONOO- generation. NO treatment caused a decrease in contraction of BCA to 0.1-3 mu M serotonin (5-HT), This suppression of contraction to 5-HT was completely prevented by preincubation prior to NO exposure with agents that prevent endogenous O-2(radical anion), production (10 mu M diphenyliodonium) or trap intracellular O-2(radical anion) (10 mM Tiron) or ONOO- (0.1 mM urate), and by post-NO treatment with an agent that traps NO (1 mu M oxyhemoglobin) or prevents the stimulation of cGMP production by NO (10 mu M methylene blue). The NO treatment caused a subsequent release of NO (measured in the head space after a B-min equilibration with 95% N-2-5% CO2), and this subsequent release of NO was reduced by the presence of urate during NO exposure and by depletion of endogenous tissue glutathione (by pretreatment with 7 mM diethyl maleate), Thus, exposure of BCA to elevated physiological levels of NO causes a prolonged suppression of contraction to 5-HT which appears to result from endogenous ONOO- formation and a thiol-dependent process that traps and subsequently releases vascular relaxant levels of NO. (C) 1997 Academic Press.
引用
收藏
页码:244 / 253
页数:10
相关论文
共 34 条
  • [1] URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS
    AMES, BN
    CATHCART, R
    SCHWIERS, E
    HOCHSTEIN, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11): : 6858 - 6862
  • [2] NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE
    BOLOTINA, VM
    NAJIBI, S
    PALACINO, JJ
    PAGANO, PJ
    COHEN, RA
    [J]. NATURE, 1994, 368 (6474) : 850 - 853
  • [3] QUANTITATION OF NITRIC-OXIDE FORMATION FROM NITROVASODILATOR DRUGS BY CHEMILUMINESCENCE ANALYSIS OF HEADSPACE GAS
    BRIEN, JF
    MCLAUGHLIN, BE
    NAKATSU, K
    MARKS, GS
    [J]. JOURNAL OF PHARMACOLOGICAL METHODS, 1991, 25 (01): : 19 - 27
  • [4] Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57
  • [5] Nitrogen dioxide causes pulmonary arterial relaxation via thiol nitrosation and NO formation
    Davidson, CA
    Kaminski, PM
    Wu, MD
    Wolin, MS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 270 (03): : H1038 - H1043
  • [6] OXIDATION OF NITROGEN-OXIDES BY BOUND DIOXYGEN IN HEMOPROTEINS
    DOYLE, MP
    HOEKSTRA, JW
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1981, 14 (04) : 351 - 358
  • [7] LUMINOL AND LUCIGENIN AS DETECTORS FOR O2.-
    FAULKNER, K
    FRIDOVICH, I
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1993, 15 (04) : 447 - 451
  • [8] Mechanism of the nitrosation of thiols and amines by oxygenated center dot NO solutions: The nature of the nitrosating intermediates
    Goldstein, S
    Czapski, G
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (14) : 3419 - 3425
  • [9] GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211
  • [10] GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181